FDA Announces Flexibility on New Food Nutrition and Supplement Labeling Regulati
On September 18, 2020, FDA announced additional flexibility measures for manufacturers who need to comply with updated labeling requirements for nutrition and supplements by January 1, 2021. For manufacturers with less than $10 million in annual food sales, while the compliance date will remain in effect, FDA will not focus enforcement actions on these smaller food manufacturers during 2021. In addition, given that manufacturers may need more time to meet requirements during the new coronary period, the FDA is offering the same flexibility measures to companies with $10 million or more in annual sales that need to comply with nutrition and supplement labeling requirements by January 1, 2020.
Korea recognizes ginseng for bone health
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. FDA plans to develop a new method for the determination of sulfite in food
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
Recommend Reading
-
![Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports]()
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
![UK’s £350 Million Critical Chemicals Fund Enters Formal Review, Offering Up to 50% Support Per Project]()
UK’s £350 Million Critical Chemicals Fund Enters Formal Review, Offering Up to 50% Support Per Project
-
![EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments]()
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
![FDA Reopens the Raw Manure Debate]()
FDA Reopens the Raw Manure Debate
-
![FDA and NIH Launch a New Nutrition Science Partnership]()
FDA and NIH Launch a New Nutrition Science Partnership
-
![Business Society’s August 20, 2026 Melamine Market Outlook: Fluctuating Trend]()
Business Society’s August 20, 2026 Melamine Market Outlook: Fluctuating Trend
-
![China's Urea Market Shows Weak Performance (3.13-3.19)]()
China's Urea Market Shows Weak Performance (3.13-3.19)
-
![U.S.-Iran Negotiations Make Progress, Dragging Oil Prices Down by Over 3%; Market May Remain Volatile in the Coming Period]()
U.S.-Iran Negotiations Make Progress, Dragging Oil Prices Down by Over 3%; Market May Remain Volatile in the Coming Period
-
![Styrene-butadiene rubber market prices surge and then fall]()
Styrene-butadiene rubber market prices surge and then fall
-
![Rate of Change Remains Positive—Retail Prices for Refined Oil Products Are Set to Rise in This Round]()
Rate of Change Remains Positive—Retail Prices for Refined Oil Products Are Set to Rise in This Round
